Skip to Content

Posts tagged with "The Scientific Literature"

  • The Scientific Literature

    Sci-Hub And Its Users

    I’ve been meaning to link to this article by John Bohannon on Sci-Hub, the gigantic paper-sharing (well, paper-pirating) service. The person behind the site (Alexandra Elbakyan) provided him with a large amount of data on the download requests it receives, and the overall picture is very interesting. Nation by nation, the single biggest user… Read More
  • How To Get a Pharma Job

    How Much Do Good Publications Count?

    A reader sends along a question that has been on the minds of many a grad student and post-doc over the years. He’s working away on his project, and trying to get work published. And naturally enough, he’d like to see it in the best possible journal, but what if the best possible journals turn… Read More
  • Chemical News

    The Chemistry Time Machine

    When I’m looking through the current literature, I sometimes try a thought experiment: what, I wonder, would I have made of these papers if I could have seen them back when I was in graduate school? If in 1986 some time warp had started leaking in the 2016 table of contents from the Journal of… Read More
  • The Scientific Literature

    Why SciHub Might Not Matter

    When I wrote recently on the topic of SciHub, the pirate-all-the-papers web site, there were many comments on the post itself, and I received quite a few by email and through Twitter. I wanted to revisit things a bit in light of those. A good place to start is this post by Stewart Lyman. He identifies the… Read More
  • The Scientific Literature

    Thoughts on Sci-Hub

    You’ll probably have heard about Sci-Hub. This site was set up by Alexandra Elbakyan with the intention of making as many copyrighted journal articles as possible available for free, and I would have to say that this goal has been realized. Current figures are over 48 million articles, which means what you think it means: Read More
  • Graduate School

    Retracting a PhD Degree, and Heading to Court

    The circus is coming to town – that’s the only conclusion I can immediately draw from this post at Retraction Watch. It provides an update on something I blogged about last in 2014, the fallout from a retracted paper from the Martin group at UT-Austin. When last heard from, the university was trying to retract… Read More
  • Diabetes and Obesity

    Three Not-So-Reproducible Papers

    You may well remember Amgen’s statement in 2012 about how many academic papers they were having trouble reproducing. Not everyone has taken it seriously, since they didn’t provide specific details, just an overall count. (On the other hand, a lot of people inside the drug industry just nodded their heads, having had similar – and… Read More
  • Clinical Trials

    Research Parasites, You’re OK By Me

    Jeffrey Drazen at the New England Journal of Medicine has clearly taken note of the reaction to the “research parasites” editorial that caused so much criticism recently. Here’s a “that’s not what I meant to say” follow-up: We want to clarify, given recent concern about our policy, that the Journal is committed t… Read More
  • Biological News

    Why This CRISPR Article, and Why Now?

    I mentioned the CRISPR patent fight here the other day, but that’s not the only front where conflict has broken out. Cell has published a piece by Eric Lander called “The Heroes of CRISPR” that’s attracting some controversy, for example. The problem is that Lander (at the Broad Institute) is unlikely to be a completely… Read More
  • The Scientific Literature

    Correcting the Literature: Not Easy

    Remember the infamous “reactome” paper? That one came out in Science in late 2009, and quickly attracted criticism from synthetic organic chemists. Supposedly, a nanoparticle-based assay was developed that immobilized and detected over 1600 endogenous molecules, but the chemistry behind the whole thing looked very shaky indeed. Later in… Read More
...456...